Bouncing of a Previous Primary trendline. MACD daily is curling and volume is coming in. Entry PT 1.65. Exit PT1: 2.50 (2-4 weeks)
This is the short-term play. JAGX is a nice breakout after 4 touches the trendline and trading at $1.75. My prediction in the short term is that JAGX would reach $2.65 next week (around 50% gain), set STOP LOSS below $1.58 (around 10% loss). Trading with a small amount (less than $5000)....
TICKER CODE: JAGX Company Name: JAGUAR HEALTH, INC US Stocks Health Technology Pharmaceuticals: Generic Position Proposed: BUY BUY ENTRY: NOW READY (1.90-2.40) 1st Partial Take Profit: 5.45 (in 2 Months 2021) 2nd Partial Take Profit: 8.25 (Aug-Sept 2021) 3rd Partial Take Profit: 12.70 (End 2021) Expected Take Profit: 17.15 (Early - Mid 2022) Potential Take...
JAGX - JUN 8 shows us a cup and handle if its broke up 2.00 thats mean we will see 2.50 - 3.00 good luck with it
Hopefully you find the chart helpful in terms of Supports & Resistance etc. we refrain from adding commentary on the chart as that is reserved for our members and we are very conscious of not giving financial or trading advice. Thank you for taking time to consult our chart and we would really appreciate a like, follow or comment.
Long as long price is above its EMA200 on an hourly basis - Stop Loss below EMA200 hourly close
If the EMA 200 on the hourly timeframe can be broken - go long. If not, stay away till it does.
NASDAQ:JAGX Possible Scenario: LONG Evidence: Price Action Call options, Strike 2.5$, 05/21/21 *It's ready to fly. This is my idea and could be wrong 100%,
Jagx bottoming out at the 1.19 area. The number 18 (+/- 2), in general is significant for JAGX. Curious to see if it holds or continues down to 1.08 (+/- 2). If all things remain the same and bounces from here-I have an launch point out of the pyramid at 1.43 ( another significant number)- then the rebirth begins. The upper box clearly was rejected at 3.34...
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through two reportable segments, Human Health and Animal Health. The company, through its subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and...
Possible fakeout to the downside then 🚀 Just an idea..not a trading advice
The weekly chart looks like a textbook Primary W1 to W2 setup, with a hollow green candle last week from the previous weeks low. The primary wave 3 target here is $8.29, with a final Wave 5 target of $10.46. The weekly RSI is curving up, hoever the momentum has been falling and the stoch RSI is still trending downward, so we could see a slight dip if the overall...
Extremely bullish on Jaguar Health this month